Who are Celcuity Inc.'s main suppliers?

Celcuity Inc. (CELC) key suppliers include: Pfizer Inc., Pfizer Inc.. View the full supplier network at chainsifter.com/chain/CELC.

Who are Celcuity Inc.'s major customers?

Celcuity Inc. (CELC) key customers include: CAPITAL-RESOURCES, LIQUIDITY-ORGANIZATION-CELCUITY-INC. View the full customer network at chainsifter.com/chain/CELC.

What sector is Celcuity Inc. in?

Celcuity Inc. (CELC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Celcuity Inc. (CELC) Suppliers & Customers

2Suppliers

2Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Celcuity Inc. (CELC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

1Distinct source URLs

6High confidence

0.835Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Celcuity Inc. Suppliers

Ticker	Name	Confidence	Evidence
PFE	Pfizer Inc.	92%	The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.
PFE	Pfizer Inc.	92%	Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.

Celcuity Inc. Customers

Ticker	Name	Confidence	Evidence
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	26 and 2025, we reported a net loss of $52.8 million and $37.0 million, respectively. As of March 31, 2026, we had an accumulated deficit of $501.7 million and cash, cash equivalents and short-term i…
LIQUIDITY-ORGANIZATION-CELCUITY-INC	LIQUIDITY-ORGANIZATION-CELCUITY-INC	62%	ectations regarding our ability to obtain and maintain intellectual property protection for gedatolisib, including its formulations and methods of use. These statements involve known and unknown risk…

Celcuity Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CELC-DEBT	Debt stack $5,830	90%	Market cache reports total debt of $5,830.
CELC-DEBT-8578	Warrants outstanding: 1827357	90%	xbrl warrant detail from xbrl 2025-12-31.
CELC-DEBT-8579	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Celcuity Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Celcuity Inc..

Celcuity Inc. Ownership

Holder	Name	Confidence	Evidence
CELC-OWNER-BAKER-BROS-ADVISORS-LP	BAKER BROS. ADVISORS LP	90%	13F overlay lists BAKER BROS. ADVISORS LP as top holder; 281 tracked holders.

Celcuity Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
PFE	Pfizer Inc.	100.00	1	['supplier']
CELG-RI	BRISTOL MYERS SQUIBB CO	50.00	2
ORANY	ORANGE	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
CAH	Cardinal Health, Inc.	50.00	2
ARVN	Arvinas, Inc.	50.00	2
RLAY	Relay Therapeutics, Inc.	50.00	2
SPRO	Spero Therapeutics, Inc.	50.00	2
HBIO	Harvard Bioscience, Inc.	50.00	2
ESPR	Esperion Therapeutics, Inc.	50.00	2
NVAX	Novavax, Inc.	50.00	2
ESGL	ESGL Holdings Limited	50.00	2
NRIX	Nurix Therapeutics, Inc.	50.00	2
ITRM	Iterum Therapeutics PLC	50.00	2
ROIV	Roivant Sciences Ltd.	50.00	2
PYXS	Pyxis Oncology, Inc.	50.00	2
OPK	OPKO Health, Inc.	50.00	2
PLX	Protalix BioTherapeutics, Inc.	50.00	2
ZLAB	Zai Lab Limited	50.00	2

Celcuity Inc. Supply Chain